WuXi, Regulus join for oligonucleotides | March 5, 2018 Issue - Vol. 96 Issue 10 | Chemical & Engineering News
Volume 96 Issue 10 | pp. 10-11 | Concentrates
Issue Date: March 5, 2018

WuXi, Regulus join for oligonucleotides

Department: Business
Keywords: Outsourcing, oligonucleotides, manufacturing, research

WuXi AppTec’s STA Pharmaceutical contract manufacturing business and Regulus Therapeutics have launched an oligonucleotide synthesis and manufacturing collaboration. STA will work with the biotech firm on preclinical and clinical programs for microRNA-targeting drugs used to treat unspecified diseases. Regulus will provide technical support and training for the Chinese firm on oligonucleotide scale-up. STA recently established oligo labs in San Diego and Changzhou, China. The company plans to open an oligo-manufacturing facility in Changzhou this year.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment